Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

4.02USD
19 Mar 2019
Change (% chg)

-- (--)
Prev Close
$4.02
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
14,074
52-wk High
$5.34
52-wk Low
$2.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 1.50 1.50 1.50 --
Quarter Ending Jun-19 1 1.50 1.50 1.50 --
Year Ending Dec-19 2 3.00 6.00 0.00 --
Earnings (per share)
Quarter Ending Mar-19 1 -0.04 -0.04 -0.04 -0.28
Quarter Ending Jun-19 1 -0.03 -0.03 -0.03 -0.30
Year Ending Dec-19 2 -0.39 -0.12 -0.66 -1.20
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.72 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta 1.54 1.08 0.87
Price to Sales (TTM) -- 49.53 8.39
Price to Book (MRQ) 10.34 10.19 5.27
Price to Tangible Book (MRQ) 10.39 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 12.71 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate 16.50 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 10.80 3.50 2.98
LT Debt to Equity (MRQ) 0.00 19.49 11.35
Total Debt to Equity (MRQ) 0.00 32.17 16.02
Interest Coverage (TTM) -- -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.46 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.47 12.43
Operating Margin (TTM) -- -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.95 8.02
Pre-Tax Margin (TTM) -- -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.74 8.31
Net Profit Margin (TTM) -- -182.46 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.13 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,655,536 820,340,930
Net Income/Employee (TTM) -- 513,853 92,858,387
Receivable Turnover (TTM) -- 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.00 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 6.36 10.60
Return on Assets - 5 Yr. Avg. -71.19 5.46 11.78
Return on Investment (TTM) -52.76 8.89 13.82
Return on Investment - 5 Yr. Avg. -91.15 6.77 15.32
Return on Equity (TTM) -52.76 10.00 15.25
Return on Equity - 5 Yr. Avg. -93.46 8.29 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.41 -8.67 23 99
13 Week -10.67 -15.02 32 95
26 Week 0.25 -7.37 54 98
52 Week 66.12 40.80 82 71
YTD 58.27 38.99 76 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.20%
# of Holders: 40
Total Shares Held: 2,526,136
3 Mo. Net Change: 77,588
# New Positions: 3
# Closed Positions: 6
# Increased Positions: 11
# Reduced Positions: 9
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.